» Articles » PMID: 32462695

Coinfection with SARS-CoV-2 and Other Respiratory Pathogens in Patients with COVID-19 in Guangzhou, China

Overview
Journal J Med Virol
Specialty Microbiology
Date 2020 May 29
PMID 32462695
Citations 32
Authors
Affiliations
Soon will be listed here.
Citing Articles

Respiratory Virus-Specific and Time-Dependent Interference of Adenovirus Type 2, SARS-CoV-2 and Influenza Virus H1N1pdm09 During Viral Dual Co-Infection and Superinfection In Vitro.

Stincarelli M, Arvia R, Guidotti B, Giannecchini S Viruses. 2025; 16(12.

PMID: 39772252 PMC: 11680187. DOI: 10.3390/v16121947.


High frequency of co-infection between SARS-CoV-2 and respiratory Adenoviruses in the Pediatric population in Hamadan, Iran.

Ali N, Nastaran A, Ali T, Farid A Niger Med J. 2024; 65(1):31-39.

PMID: 39006178 PMC: 11238167. DOI: 10.60787/nmj-v65i1-449.


Transcriptome Analysis of LLC-PK Cells Single or Coinfected with Porcine Epidemic Diarrhea Virus and Porcine Deltacoronavirus.

Lu Y, Yu R, Tong L, Zhang L, Zhang Z, Pan L Viruses. 2024; 16(1).

PMID: 38257774 PMC: 10818665. DOI: 10.3390/v16010074.


Fungal-Bacterial Co-Infections and Super-Infections among Hospitalized COVID-19 Patients: A Systematic Review.

Bantun F J Fungi (Basel). 2023; 9(6).

PMID: 37367534 PMC: 10299597. DOI: 10.3390/jof9060598.


Co-infection of respiratory pathogens in SARS-CoV-2 positive patients at North West India, Rajasthan.

Gautam S, Malhotra B, Sharma P, Bhomia N, Deeba F, Sharma H Indian J Med Microbiol. 2023; 44:100371.

PMID: 37356835 PMC: 10173797. DOI: 10.1016/j.ijmmb.2023.100371.


References
1.
Guan W, Zhong N . Clinical Characteristics of Covid-19 in China. Reply. N Engl J Med. 2020; 382(19):1861-1862. DOI: 10.1056/NEJMc2005203. View

2.
Lagunas-Rangel F . Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020; 92(10):1733-1734. PMC: 7228336. DOI: 10.1002/jmv.25819. View

3.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

4.
Koehler P, Cornely O, Bottiger B, Dusse F, Eichenauer D, Fuchs F . COVID-19 associated pulmonary aspergillosis. Mycoses. 2020; 63(6):528-534. PMC: 7267243. DOI: 10.1111/myc.13096. View

5.
Banerjee A, Nasir J, Budylowski P, Yip L, Aftanas P, Christie N . Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020; 26(9):2054-2063. PMC: 7454076. DOI: 10.3201/eid2609.201495. View